血小板糖蛋白(GP)Ⅱb/Ⅲa受体拮抗剂及在冠心病临床应用的研究进展
田建伟,刘朝中,江一清
空军总医院心内科!北京100036空军总医院心内科!北京100036空军总医院心内科!北京100036
Abstract: 血小板在动脉粥样硬化、血栓形成以及急性冠脉综合征中起着非常重要的作用。血小板糖蛋白 GP b/ a受体拮抗剂通过与血小板膜上的 GP b/ a受体结合抑制血小板凝集 ,是一种新型高效的血小板抑制剂。目前已广泛地应用于冠心病、不稳定性心绞痛、急性心肌梗死 (AMI)及冠心病介入治疗后并发症的防治。大系列的临床研究已取得了降低并发症及病死率的显著疗效。
Keywords:
- DOI:
10.13191/j.chj.2000.04.56.tianjw.026
- Series:
- Subject:
- Classification Code:
R541.4
- Mobile Reading
Read on your phone instantly
Step 1Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3Scan QR Codes
Read this article on your phone.
- HTML
- CAJ Download
- PDF Download
Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 111 Page: 306-308 Pagecount: 3 Size: 88k
Citation Network
Related Literature
- Similar Article
- Reader Recommendation
- Associated Author